CLINICAL_TRIALS
trial_result
· 2009-07-14
Clinical Trial Update: Study of Oral CNF2024 (BIIB021) in Advanced Solid Tumors [Phase 1]
Summary
A Phase 1 study of oral CNF2024 (BIIB021) in advanced solid tumors and lymphoma has completed.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Biogen | Conditions: Tumors, Lymphoma | Phase 1 | Status: COMPLETED